Sectors & Industries HealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2026)
Top pharmaceutical stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best pharmaceutical stocks to buy now. Learn More.

Industry: Drug Manufacturers - Spec...

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Pharmaceutical is Zen Rated B and is the 42nd ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
BHC	BAUSCH HEALTH COMPANIES INC	$2.12B	N/A	-4.30%	4.30%	3.40%	-14.45	1.44	71.80%	-10.10%	8.02%
ETON	ETON PHARMACEUTICALS INC	$1.59B	40.10%	12.40%	23.07%	66.30%	1.49	1.52	57.90%	12.00%	15.44%
INDV	INDIVIOR PHARMACEUTICALS INC	$4.12B	-216.10%	28.10%	115.07%	76.30%	-6.93	0.84	82.00%	26.70%	31.53%
KMDA	KAMADA LTD	$510.52M	8.40%	5.80%	8.30%	17.10%	0.42	4.06	40.80%	11.60%	14.45%
PRGO	PERRIGO CO PLC	$1.88B	-56.00%	-20.30%	-22.59%	-24.20%	2.03	2.32	33.30%	-41.90%	-35.73%
AMRX	AMNEAL PHARMACEUTICALS INC	$5.98B	-326.80%	4.30%	12.81%	9.00%	113.35	2.21	39.30%	5.00%	11.89%
ANIP	ANI PHARMACEUTICALS INC	$1.75B	19.60%	7.50%	13.15%	16.80%	1.50	2.91	60.40%	11.00%	16.27%
ELAN	ELANCO ANIMAL HEALTH INC	$11.20B	-3.00%	-1.50%	0.70%	1.10%	1.06	2.05	55.40%	-4.00%	1.63%
AMPH	AMPHASTAR PHARMACEUTICALS INC	$1.00B	10.10%	4.70%	8.66%	9.40%	1.27	2.40	47.70%	10.80%	17.55%
PCRX	PACIRA BIOSCIENCES INC	$984.19M	2.10%	1.20%	2.95%	3.20%	0.85	5.04	79.20%	2.00%	4.44%
HCM	HUTCHMED (CHINA) LTD	$2.38B	1.40%	1.00%	1.53%	1.60%	0.37	5.64	41.60%	3.30%	4.08%
VTRS	VIATRIS INC	$19.47B	-2.80%	-1.10%	-0.63%	-0.90%	1.46	1.59	34.80%	-2.80%	-1.24%
IRWD	IRONWOOD PHARMACEUTICALS INC	$720.45M	-57.40%	34.30%	95.15%	42.00%	-2.76	6.06	100.00%	33.40%	61.66%
TAK	TAKEDA PHARMACEUTICAL CO LTD	$59.77B	-2.20%	-1.10%	1.42%	2.10%	1.07	1.14	65.50%	-3.50%	3.98%
TKNO	ALPHA TEKNOVA INC	$418.23M	-24.90%	-16.50%	-17.75%	-14.90%	0.53	4.49	34.60%	-38.40%	-36.16%
HLN	HALEON PLC	$41.54B	N/A	N/A	N/A	N/A	0.99	0.69	N/A	N/A	N/A
EOLS	EVOLUS INC	$519.16M	N/A	-15.00%	-11.70%	-9.00%	-9.03	1.70	66.70%	-10.80%	-5.52%
DERM	JOURNEY MEDICAL CORP	$206.32M	-20.20%	-6.60%	-4.60%	-9.60%	2.06	1.59	65.50%	-9.00%	-3.55%
PAHC	PHIBRO ANIMAL HEALTH CORP	$1.40B	28.70%	7.00%	15.34%	10.50%	2.90	2.96	33.80%	6.60%	11.97%
LQDA	LIQUIDIA CORP	$5.99B	149.60%	36.30%	52.95%	86.10%	1.68	2.31	92.50%	30.70%	39.06%
BFRI	BIOFRONTERA INC	$19.61M	-127.80%	-27.40%	-43.28%	-52.50%	3.04	1.18	79.30%	-13.80%	-12.68%
EBS	EMERGENT BIOSOLUTIONS INC	$348.66M	-35.90%	-13.60%	-9.57%	-8.10%	2.27	5.42	55.90%	-23.00%	-12.35%
NBIX	NEUROCRINE BIOSCIENCES INC	$14.86B	21.10%	14.70%	21.03%	28.30%	0.45	1.87	98.00%	20.90%	27.95%
CRON	CRONOS GROUP INC	$1.23B	6.50%	5.90%	1.80%	5.90%	0.06	16.18	45.90%	39.10%	11.32%
PBH	PRESTIGE CONSUMER HEALTHCARE INC	$2.13B	9.20%	4.60%	6.35%	16.30%	1.38	3.23	53.50%	15.60%	25.37%
ALKS	ALKERMES PLC	$7.28B	3.70%	2.00%	4.19%	9.00%	1.43	2.30	84.60%	4.00%	9.38%
SCYX	SCYNEXIS INC	$44.38M	-21.10%	-15.60%	-14.80%	-25.70%	0.12	9.65	100.00%	-53.30%	-53.27%
COLL	COLLEGIUM PHARMACEUTICAL INC	$741.29M	16.00%	2.70%	9.97%	15.50%	5.85	1.03	60.00%	5.90%	19.07%
CPHI	CHINA PHARMA HOLDINGS INC	$30.55M	-17.20%	-13.10%	-11.82%	-156.20%	0.24	0.26	11.80%	-114.30%	-111.80%
TLPH	TALPHERA INC	$60.21M	-87.30%	-51.40%	-66.65%	-52.80%	0.86	4.30	100.00%	-1,507,600.00%	-1,507,600.00%
OGI	ORGANIGRAM GLOBAL INC	$148.02M	22.00%	14.20%	11.40%	28.60%	0.69	2.61	36.50%	28.00%	26.29%
ZTS	ZOETIS INC	$29.50B	69.30%	17.20%	26.97%	21.60%	3.79	3.08	71.50%	27.50%	36.88%
SIGA	SIGA TECHNOLOGIES INC	$225.61M	-1.50%	-1.30%	-3.28%	-16.10%	0.06	21.72	54.40%	-5.20%	-10.27%
IXHL	INCANNEX HEALTHCARE INC	$43.55M	-81.00%	-76.10%	-61.79%	-1,739.50%	0.07	41.57	N/A	N/A	N/A
UPC	UNIVERSE PHARMACEUTICALS INC	$2.74M	-3.50%	-2.60%	-2.96%	-6.00%	0.28	4.05	36.50%	-10.90%	-9.65%
TRLV	TRULIEVE CANNABIS CORP	$2.13B	-44.20%	-18.00%	-13.71%	-16.10%	1.71	5.94	59.50%	-41.60%	-23.85%
LFCR	LIFECORE BIOMEDICAL INC	$168.82M	N/A	-18.70%	-3.73%	-2.40%	-6.26	3.87	30.30%	-32.50%	-5.83%
CRDL	CARDIOL THERAPEUTICS INC	$217.28M	-180.10%	-140.00%	-141.43%	1,321.80%	0.22	5.55	N/A	N/A	N/A
CPIX	CUMBERLAND PHARMACEUTICALS INC	$109.68M	-48.50%	-15.80%	-38.19%	-40.50%	2.63	0.96	83.50%	-34.90%	-33.81%
HROW	HARROW INC	$1.24B	-103.90%	-9.30%	-3.32%	-3.20%	26.45	2.24	73.30%	-13.50%	-3.79%
ACB	AURORA CANNABIS INC	$245.01M	-26.40%	-20.20%	-24.88%	-29.00%	0.18	5.36	49.70%	-48.00%	-46.96%
AQST	AQUESTIVE THERAPEUTICS INC	$578.61M	N/A	-52.40%	-53.54%	-44.30%	-3.34	7.19	67.00%	-144.60%	-114.45%
CGC	CANOPY GROWTH CORP	$395.12M	-32.80%	-21.50%	-25.22%	-32.50%	0.60	3.04	25.20%	-80.40%	-80.49%
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	$2.86B	N/A	N/A	N/A	N/A	1.47	1.42	N/A	N/A	N/A
RDY	DR REDDYS LABORATORIES LTD	$10.17B	12.10%	8.00%	14.31%	18.40%	0.53	1.80	52.80%	12.80%	17.54%
SXTC	CHINA SXT PHARMACEUTICALS INC	$28.74k	-27.50%	-22.00%	-20.20%	-668.40%	0.17	7.94	2,169,246.30%	-15,134,353.70%	-14,980,780.49%
ALVO	ALVOTECH	$2.09B	N/A	-12.20%	10.08%	5.40%	-9.29	1.65	60.70%	-36.30%	25.61%
TLRY	TILRAY BRANDS INC	$543.45M	-7.70%	-5.70%	-4.09%	-6.90%	0.45	2.21	28.40%	-13.30%	-8.81%
GLAS	GLASS HOUSE BRANDS INC	$661.92M	-68.50%	-16.40%	-14.33%	-11.60%	2.04	1.33	30.80%	-31.70%	-22.61%
SHPH	SHUTTLE PHARMACEUTICALS HOLDINGS INC	$1.88M	-408.30%	-138.10%	-306.82%	303.00%	2.53	0.30	N/A	N/A	N/A
ORGO	ORGANOGENESIS HOLDINGS INC	$182.72M	-44.70%	-20.80%	-10.13%	-9.20%	0.80	3.52	70.40%	-23.10%	-7.74%
BIOA	BIOAGE LABS INC	$369.93M	-29.00%	-27.10%	-24.94%	-61.30%	0.06	17.19	100.00%	-912.30%	-909.54%
AKAN	AKANDA CORP	$2.53M	N/A	-647.10%	1,222,546.98%	-642.50%	-1.52	0.58	-60.50%	-17,690.20%	-18,048.64%
CABR	CARING BRANDS INC	$14.52M	N/A	-412.00%	-486.58%	6,882.90%	-0.14	4.97	59.20%	-850,598.30%	-639,678.71%
RMTI	ROCKWELL MEDICAL INC	$32.53M	-14.00%	-8.90%	-8.71%	-10.10%	0.61	3.25	17.70%	-7.30%	-5.69%
PRFX	PRF TECHNOLOGIES LTD	$3.10M	N/A	N/A	N/A	N/A	0.17	5.07	-306.50%	N/A	N/A
RDHL	REDHILL BIOPHARMA LTD	$0.00	N/A	-2.00%	-4.75%	3.60%	4.94	0.34	100.00%	-150.00%	-101.75%
LNTH	LANTHEUS HOLDINGS INC	$6.56B	23.30%	11.90%	18.41%	33.70%	0.84	3.06	60.10%	17.70%	24.60%
OPTH	OPTIMI HEALTH CORP	$28.34M	N/A	N/A	N/A	N/A	0.47	1.73	N/A	N/A	N/A
TXMD	THERAPEUTICSMD INC	$25.35M	-0.80%	-0.60%	-0.58%	-0.70%	0.38	3.22	100.00%	-6.60%	-5.78%
INCR	INTERCURE LTD	$58.07M	-9.00%	-4.90%	-2.42%	-2.80%	0.74	0.96	12.30%	-13.20%	-4.27%
GELS	GELTEQ LTD	$6.29M	-42.90%	-31.30%	-34.03%	2,269.20%	0.42	0.09	30.30%	-4,276.10%	-2,928.76%
KALA	KALA BIO INC	$10.42M	-222.30%	-70.20%	-99.25%	-193.60%	0.17	6.88	N/A	N/A	N/A
CTOR	CITIUS ONCOLOGY INC	$106.00M	-103.00%	-43.50%	-85.37%	-89.60%	1.78	0.73	77.30%	-648.30%	-640.47%
SUPN	SUPERNUS PHARMACEUTICALS INC	$2.44B	-10.40%	-7.60%	-11.21%	-40.90%	0.39	2.08	88.10%	-13.20%	-14.59%
SNOA	SONOMA PHARMACEUTICALS INC	$6.13M	-53.60%	-15.20%	-19.80%	-33.20%	1.75	2.99	38.90%	-10.30%	-11.44%
SBFM	SUNSHINE BIOPHARMA INC	$3.49M	-24.20%	-18.90%	-19.85%	-40.80%	0.22	5.46	30.30%	-16.50%	-15.73%
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	$45.42B	9.10%	1.80%	6.67%	7.80%	4.14	0.88	52.50%	4.10%	9.33%
YCBD	CBDMD INC	$5.04M	-36.50%	-25.90%	-28.75%	-56.30%	0.60	2.50	57.70%	-14.70%	-13.83%
ZYBT	ZHENGYE BIOTECHNOLOGY HOLDING LTD	$64.93M	-26.10%	-15.00%	-17.50%	-16.10%	0.52	1.14	20.50%	-60.00%	-47.51%
BGM	BGM GROUP LTD	$55.38M	-7.30%	-6.60%	-4.11%	-54.70%	0.09	1.25	16.90%	-44.20%	-34.30%
AYTU	AYTU BIOPHARMA INC	$22.75M	-148.90%	-28.20%	-60.65%	-418.50%	2.18	1.12	64.80%	-60.20%	-55.42%
APUS	APIMEDS PHARMACEUTICALS US INC	$2.67M	-59.00%	-52.60%	-50.55%	-54.80%	0.20	0.51	N/A	N/A	N/A
IMCC	IM CANNABIS CORP	$2.30M	N/A	-58.30%	137.36%	-161.20%	-9.48	0.48	12.50%	-39.60%	-27.93%
EVO	EVOTEC SE	$569.31M	-32.70%	-14.50%	-19.31%	-21.80%	1.37	2.33	7.00%	-36.30%	-36.28%

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Sep 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best pharma stocks to buy right now are:

1. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the #1 top pharmaceutical stock out of 75 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bausch Health Companies (NYSE:BHC) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: C, and AI: C.

Bausch Health Companies (NYSE:BHC) has a Due Diligence Score of 6, which is -21 points lower than the pharmaceutical industry average of 27. Although this number is below the industry average, our proven quant model rates BHC as a "A".

BHC passed 2 out of 33 due diligence checks and has weak fundamentals. Bausch Health Companies has seen its stock lose -17.71% over the past year, overperforming other pharmaceutical stocks by 78 percentage points.

Bausch Health Companies has an average 1 year price target of $9.00, an upside of 58.73% from Bausch Health Companies's current stock price of $5.67.

Bausch Health Companies stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Bausch Health Companies, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Eton Pharmaceuticals (NASDAQ:ETON)

Eton Pharmaceuticals (NASDAQ:ETON) is the #2 top pharmaceutical stock out of 75 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Eton Pharmaceuticals (NASDAQ:ETON) is: Value: C, Growth: A, Momentum: A, Sentiment: B, Safety: D, Financials: A, and AI: C.

Eton Pharmaceuticals (NASDAQ:ETON) has a Due Diligence Score of 54, which is 27 points higher than the pharmaceutical industry average of 27.

ETON passed 19 out of 33 due diligence checks and has strong fundamentals. Eton Pharmaceuticals has seen its stock return 200.65% over the past year, overperforming other pharmaceutical stocks by 296 percentage points.

Eton Pharmaceuticals has an average 1 year price target of $67.50, an upside of 21.62% from Eton Pharmaceuticals's current stock price of $55.50.

Eton Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Eton Pharmaceuticals, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Indivior Pharmaceuticals (NASDAQ:INDV)

Indivior Pharmaceuticals (NASDAQ:INDV) is the #3 top pharmaceutical stock out of 75 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Indivior Pharmaceuticals (NASDAQ:INDV) is: Value: B, Growth: C, Momentum: C, Sentiment: B, Safety: B, Financials: A, and AI: C.

Indivior Pharmaceuticals (NASDAQ:INDV) has a Due Diligence Score of 53, which is 26 points higher than the pharmaceutical industry average of 27.

INDV passed 18 out of 33 due diligence checks and has strong fundamentals. Indivior Pharmaceuticals has seen its stock return 52.38% over the past year, overperforming other pharmaceutical stocks by 148 percentage points.

Indivior Pharmaceuticals has an average 1 year price target of $43.00, an upside of 23.28% from Indivior Pharmaceuticals's current stock price of $34.88.

Indivior Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Indivior Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 8 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals (NASDAQ:CPIX) has an annual dividend yield of 20.49%, which is 16 percentage points higher than the pharmaceutical industry average of 4.65%.

Cumberland Pharmaceuticals's dividend payout ratio of -411% indicates that its high dividend yield might not be sustainable for the long-term.

2. Perrigo Co (NYSE:PRGO)

Perrigo Co (NYSE:PRGO) has an annual dividend yield of 6.42%, which is 2 percentage points higher than the pharmaceutical industry average of 4.65%. Perrigo Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Perrigo Co's dividend has shown consistent growth over the last 10 years.

Perrigo Co's dividend payout ratio of -9.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Kamada (NASDAQ:KMDA)

Kamada (NASDAQ:KMDA) has an annual dividend yield of 4.74%, which is the same as the pharmaceutical industry average of 4.65%.

Kamada's dividend payout ratio of 65.7% indicates that its high dividend yield is sustainable for the long-term.

Why are pharmaceutical stocks down?

Pharmaceutical stocks were down -1.09% in the last day, and down -0.16% over the last week.

We couldn't find a catalyst for why pharmaceutical stocks are down.

What are the most undervalued pharmaceutical stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued pharmaceutical stocks right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 71, which is 53 points higher than the pharmaceutical industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 198.63% in the past year. It has overperformed other stocks in the pharmaceutical industry by 294 percentage points.

2. Amphastar Pharmaceuticals (NASDAQ:AMPH)

Amphastar Pharmaceuticals (NASDAQ:AMPH) is the second most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Amphastar Pharmaceuticals has a valuation score of 43, which is 25 points higher than the pharmaceutical industry average of 18. It passed 3 out of 7 valuation due diligence checks.

Amphastar Pharmaceuticals's stock has dropped -13.92% in the past year. It has overperformed other stocks in the pharmaceutical industry by 82 percentage points.

3. Zoetis (NYSE:ZTS)

Zoetis (NYSE:ZTS) is the third most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Zoetis has a valuation score of 14, which is -4 points higher than the pharmaceutical industry average of 18. It passed 1 out of 7 valuation due diligence checks. Although this number is below the industry average, our proven quant model rates ZTS a Valuation Rating of "A".

Zoetis's stock has dropped -51.46% in the past year. It has overperformed other stocks in the pharmaceutical industry by 44 percentage points.

Are pharmaceutical stocks a good buy now?

48.78% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 47.57% over the next year.

11.32% of pharmaceutical stocks have a Zen Rating of A (Strong Buy), 26.42% of pharmaceutical stocks are rated B (Buy), 41.51% are rated C (Hold), 18.87% are rated D (Sell), and 1.89% are rated F (Strong Sell).

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is 2.19x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.